Innovation Pharmaceuticals Inc (IPIX)

[petemantx]

Locust Walk came on board prior to CV19. At that time, company was in dire need of money to advance OM and IBD trials. Financial situation was severe. Partner seemed the only way out for at least one indication to get money to advance other indications.

Now w/ CV19 money situation totally changed and the need for IPIX to secure a BP partner is way low on the totem pole IMO. This is due to them having about $6MM in the bank and $30MM in the "just ask for it" line with Aspire. They can pick and choose instead of having to take toxic financing.

Things should change even more for the better by the end of the year when we should have human trial results known IMO.

So many positives this year, the most excellent being the TOTAL INVESTIGATION of Brilacidin by a government RBL, which should expand even more fully in the near future, which IMO will result in some extremely lucrative partnerships for IPIX, especially in IBD and CV19.